Abstract
Gluten ataxia is an immune-mediated disease triggered by the ingestion of gluten in genetically susceptible individuals. It should be considered in the differential diagnosis of all patients with idiopathic sporadic ataxia. Early diagnosis and treatment with a gluten free diet can improve ataxia and prevent its progression. Readily available and sensitive markers of gluten ataxia include antigliadin antibodies. IgA deposits against TG2 in the small bowel and at extraintestinal sites are proving to be additional reliable and perhaps more specific markers of the whole spectrum of gluten sensitivity. They may also hold the key to its pathogenesis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hadjivassiliou M, Grünewald RA, Chattopadhyay AK, Davies-Jones GAB, Gibson A, Jarratt JA, et al. Clinical, radiological, neurophysiological and neuropathological characteristics of gluten ataxia. Lancet. 1998;352:1582–85.
Hadjivassiliou M, Grünewald RA, Sharrack B, Sanders D, Lobo A, Wood N, et al. Gluten ataxia in perspective: Epidemiology, genetic susceptibility and clinical characteristics. Brain. 2003;126:685–91.
Abele M, Schols L, Schwartz S, Klockgether T. Prevalence of antigliadin antibodies in ataxia patients. Neurology. 2003;60:1674–5.
Bushara KO, Nance M, Gomez C. Antigliadin antibodies in Huntington’s disease. Neurology. 2004;62:132–3.
Bushara KO, Goebel SU, Shill H, Goldfarb LG, Hallett M. Gluten sensitivity in sporadic and hereditary ataxia. Ann Neurol. 2001;49:540–43.
Sanders DS, Patel D, Stephenson TJ, Milford-Ward A, McCloskey EV, Hadjivassilou M, et al. A primary care crosssectional study of undiagnosed adult coeliac disease. Eur J Gastro Hep. 2003;15:407–13.
Pereira AC, Edwards MJ, Buttery PC, Hawkes CH, Quinn NP, Giovannoni G, et al. Choreic syndrome and coeliac disease: A hitherto unrecognised association. Mov Disord. 2004;19:478–82.
Deconinck N, Scaillon M, Segers V, Groswasser JJ, Dan B. Opsoclonus-myoclonus associated with celiac disease. Pediatr Neurol. 2006;34:312–14.
Hadjivassiliou M, Grünewald RAG, Lawden M, Davies-Jones GAB, Powell T, Smith CML. Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology. 2001;56:385–8.
Wilkinson ID, Hadjivassiliou M, Dickson JM, Wallis L, Grunewald RA, Coley SC, et al. Cerebellar abnormalities on proton MR spectroscopy in gluten ataxia. J Neurol Neurosurg Psychiatry. 2005;76:1011–13.
Cooke WT, Thomas-Smith W. Neurological disorders associated with adult coeliac disease. Brain. 1966;89:683–722.
Hadjivassiliou M, Boscolo S, Davies-Jones A, Grunewald R, Not T, Sanders D, et al. The humoral response in the pathogenesis of gluten ataxia. Neurology. 2002;58:1221–6.
Hadjivassiliou M, Williamson CA, Woodroofe N. The immunology of gluten sensitivity: Beyond the gut. Trends Immunol. 2004;25:278–82.
Ward ME, Murphy JT, Greenberg GR. Coeliac disease and spinocerebellar degeneration with normal vitamin E status. Neurology. 1985;35:1199–1201.
Kaplan JG, Pack D, Horoupian D, DeSouza T, Brin M, Schaumburg H. Distal axonopathy associated with chronic gluten enteropathy: A treatable disorder. Neurology. 1988;38:642–5.
Bhatia KP, Brown P, Gregory R, Lennox GG, Manji H, Thompson PD, et al. Progressive myoclonic ataxia associated with coeliac disease: The myoclonus is of cortical origin, but the pathology is in the cerebellum. Brain. 1995;118:1087–93.
Pellecchia MT, Scala R, Perretti A, De Michelle G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet. Neurology. 1999;53:1606–07.
Bürk K, Melms A, Schulz JB, Dichgans J. Effectiveness of intravenous immunoglobulin therapy in cerebellar ataxia associated with gluten sensitivity. Ann Neurol. 2001;50:827–8.
Hadjivassiliou M, Davies-Jones GAB, Sanders DS, Grünewald RAG. Dietary treatment of gluten ataxia. J Neurol Neurosurg Psychiatry. 2003;74:1221–4.
Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;7:797–801.
Korponay-Szabo IR, Halttunen T, Szalai Z, Laurila K, Kiraly R, Kovacs JB, et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut. 2004;53:641–8.
Hadjivassiliou M, Maki M, Sanders DS, Williamson C, Grunewald RA, Woodroofe N, et al. Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology. 2006;66:373–7.
Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (Tgase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 2002;195:747–57.
Pellecchia MT, Scala R, Filla A, De Michele G, Ciacci C, Barone P. Idiopathic cerebellar ataxia associated with celiac disease: Lack of distinctive neurological features. J Neurol Neurosurg Psychiatry. 1999;66:32–5.
Bürk K, Bösch S, Müller CA, Melms A, Zuhlke C, Stern M, et al. Sporadic cerebellar ataxia associated with gluten sensitivity. Brain. 2001;124:1013–19.
Abele M, Bürk K, Schöls L, Schwartz S, Bessenthal I, Bessenthal I, Dichgans, et al. The aetiology of sporadic adultonset ataxia. Brain. 2002;125:961–8.
Luostarinen LK, Collin PO, Paraaho MJ, Maki MJ, Pirttila TA. Coeliac disease in patients with cerebellar ataxia of unknown origin. Ann Med. 2001;33:445–9.
Ihara M, Makino F, Sawada H, Mezaki T, Mizutami K, Nakase H, et al. Gluten sensitivity in Japanese patients with adult-onset cerebellar ataxia. Intern Med. 2006;45:135–40.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hadjivassiliou, M., Sanders, D.S., Woodroofe, N. et al. Gluten ataxia. Cerebellum 7, 494–498 (2008). https://doi.org/10.1007/s12311-008-0052-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12311-008-0052-x